New energy research from Parks Associates finds 28% of U.S. broadband households are familiar with time-of-use rate programs, including 16% who are very familiar, but only 18% report their utility...

Kleo Pharmaceuticals Inc., a unique immuno-oncology company developing next-generation bispecific compounds designed to emulate or enhance the activity of biologics, announced today that its Chief...

Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological...

FormFast will be returning as an exhibitor to the 2019 HIMSS Annual Conference & Exhibition in Orlando, Florida February 11-15. HIMSS brings together 45,000+ health information and technology...

Ergotron, the movement company that helps people thrive by removing constraints, and UV Partners, developer of the UV Angel® automated disinfection system, today announced plans to integrate the...